NG

Naveen Gannamaneni

Active Director Director DIN 10757264
DIN 10757264 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Naveen Gannamaneni

Data last updated:

Naveen Gannamaneni is a Director at Grandis Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10757264
Primary Designation Director
Industry Pharma
First Appointment 28 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Aug 20242024Active

Board colleagues of Naveen Gannamaneni

NameDINCompanyDesignation
Shravan Kumar Surabhi07386303Grandis Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Grandis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Naveen Gannamaneni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naveen Gannamaneni

Naveen Gannamaneni currently holds 1 directorship: Grandis Pharmaceuticals Private Limited (Director, since 28 Aug 2024).

Naveen Gannamaneni was first appointed on 28 Aug 2024 as Director at Grandis Pharmaceuticals Private Limited.

The current boards of Naveen Gannamaneni's companies include Shravan Kumar Surabhi (Grandis Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available